nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ability to predict breast cancer in Asian women using a polygenic susceptibility model
|
Hartman, Mikael |
|
2010 |
127 |
3 |
p. 805-812 |
artikel |
2 |
A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer
|
Zaman, K. |
|
2011 |
127 |
3 |
p. 689-696 |
artikel |
3 |
A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
|
Long, Meijun |
|
2011 |
127 |
3 |
p. 705-712 |
artikel |
4 |
A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk
|
Wang, Furu |
|
2010 |
127 |
3 |
p. 769-775 |
artikel |
5 |
BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer
|
Wong, Michelle W. |
|
2011 |
127 |
3 |
p. 853-859 |
artikel |
6 |
CAG repeat length polymorphism in the androgen receptor gene and breast cancer risk: data on Indian women and survey from the world
|
Rajender, Singh |
|
2010 |
127 |
3 |
p. 751-760 |
artikel |
7 |
Change in blood flow velocity demonstrated by Doppler ultrasound in upper limb after axillary dissection surgery for the treatment of breast cancer
|
Nascimben Matheus, Carolina |
|
2011 |
127 |
3 |
p. 697-704 |
artikel |
8 |
Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab
|
Oliveira, Mafalda |
|
2011 |
127 |
3 |
p. 841-844 |
artikel |
9 |
Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis
|
Zhou, Ping |
|
2010 |
127 |
3 |
p. 813-818 |
artikel |
10 |
Disparities in breast cancer characteristics and outcomes by race/ethnicity
|
Ooi, Siew Loon |
|
2010 |
127 |
3 |
p. 729-738 |
artikel |
11 |
Economic evaluation of the 21-gene signature (Oncotype DX®) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03)
|
Kondo, Masahide |
|
2010 |
127 |
3 |
p. 739-749 |
artikel |
12 |
Elevated TRF2 in advanced breast cancers with short telomeres
|
Diehl, Malissa C. |
|
2010 |
127 |
3 |
p. 623-630 |
artikel |
13 |
EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry
|
Bane, Anita L. |
|
2011 |
127 |
3 |
p. 831-839 |
artikel |
14 |
Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer
|
Callari, Maurizio |
|
2010 |
127 |
3 |
p. 601-610 |
artikel |
15 |
Germline mutational analysis of the C19orf62 gene in African-American women with breast cancer
|
Zheng, Yonglan |
|
2011 |
127 |
3 |
p. 871-877 |
artikel |
16 |
GRB7 protein over-expression and clinical outcome in breast cancer
|
Ramsey, Betsy |
|
2010 |
127 |
3 |
p. 659-669 |
artikel |
17 |
IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families
|
Rosendahl, Ann H. |
|
2010 |
127 |
3 |
p. 785-794 |
artikel |
18 |
International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation
|
Peixoto, Ana |
|
2010 |
127 |
3 |
p. 671-679 |
artikel |
19 |
Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers
|
Gutiérrez-Enríquez, Sara |
|
2010 |
127 |
3 |
p. 611-622 |
artikel |
20 |
Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case–control study in Taiwan
|
Wu, Mei-Hsuan |
|
2010 |
127 |
3 |
p. 777-784 |
artikel |
21 |
MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups
|
Aleskandarany, Mohammed A. |
|
2010 |
127 |
3 |
p. 591-599 |
artikel |
22 |
Microcephalin is a new novel prognostic indicator in breast cancer associated with BRCA1 inactivation
|
Richardson, Julie |
|
2010 |
127 |
3 |
p. 639-648 |
artikel |
23 |
Native MAG-1 antibody almost destroys human breast cancer xenografts
|
North, William G. |
|
2010 |
127 |
3 |
p. 631-637 |
artikel |
24 |
Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo
|
Sato, Sumito |
|
2010 |
127 |
3 |
p. 649-657 |
artikel |
25 |
PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy
|
Domagala, Pawel |
|
2011 |
127 |
3 |
p. 861-869 |
artikel |
26 |
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
|
Cancello, G. |
|
2011 |
127 |
3 |
p. 713-720 |
artikel |
27 |
Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status
|
Figueiredo, Jane C. |
|
2010 |
127 |
3 |
p. 819-829 |
artikel |
28 |
Socioeconomic differences in survival among breast cancer patients in the Netherlands not explained by tumor size
|
Bastiaannet, E. |
|
2010 |
127 |
3 |
p. 721-727 |
artikel |
29 |
The h index and the identification of global benchmarks for breast cancer research output
|
Healy, N. A. |
|
2011 |
127 |
3 |
p. 845-851 |
artikel |
30 |
Two functional variations in 5′-UTR of hoGG1 gene associated with the risk of breast cancer in Chinese
|
Chen, Xiaoxiang |
|
2010 |
127 |
3 |
p. 795-803 |
artikel |
31 |
Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)
|
Campa, Daniele |
|
2010 |
127 |
3 |
p. 761-767 |
artikel |
32 |
Women’s interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid
|
Fagerlin, Angela |
|
2011 |
127 |
3 |
p. 681-688 |
artikel |